{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T07:19:25Z","timestamp":1783408765238,"version":"3.54.6"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jsbmb.2026.107059","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:19:09Z","timestamp":1781651949000},"page":"107059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Interferon-gamma-inducible protein-10 is associated to increased primary bile acids and fibrosis in primary sclerosing cholangitis"],"prefix":"10.1016","volume":"263","author":[{"given":"Bettina","family":"Langhans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"Dold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taotao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob S.","family":"Tr\u00e4gner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Friedrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Stellaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"L\u00fctjohann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Strassburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0882-0957","authenticated-orcid":false,"given":"Sandra","family":"Kalthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2026.107059_bib1","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib3","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.26447","article-title":"Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis","volume":"58","author":"Katt","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jsbmb.2026.107059_bib4","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000603","article-title":"Il-6-Dependent Stat3 Activation and Induction of Proinflammatory Cytokines in Primary Sclerosing Cholangitis","author":"Dold","year":"2023","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/ecco-jcc\/jjx050","article-title":"Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease","volume":"11","author":"Gwela","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.jsbmb.2026.107059_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1089\/jir.2013.0075","article-title":"Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis","volume":"34","author":"Landi","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.jsbmb.2026.107059_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1248","article-title":"STAT activation in regulatory CD4(+) T cells of patients with primary sclerosing cholangitis","volume":"12","author":"Dold","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.jsbmb.2026.107059_bib8","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jhep.2013.12.027","article-title":"Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms","volume":"60","author":"Sebode","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41575-022-00690-y","article-title":"The microbiota and the gut-liver axis in primary sclerosing cholangitis","volume":"20","author":"Hov","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00281-021-00869-6","article-title":"Role of bile acids in inflammatory liver diseases","volume":"43","author":"Evangelakos","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib11","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","article-title":"Bile Acids Activated Receptors Regulate Innate Immunity","volume":"9","author":"Fiorucci","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2567.2012.03554.x","article-title":"Bile acids induce monocyte differentiation toward interleukin-12 hypo-producing dendritic cells via a TGR5-dependent pathway","volume":"136","author":"Ichikawa","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.jsbmb.2026.107059_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut RORgamma(+) regulatory T cell homeostasis","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2026.107059_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T(H)17 and T(reg) cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2026.107059_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hep.31652","article-title":"Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation","volume":"74","author":"Mousa","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jsbmb.2026.107059_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dld.2011.10.025","article-title":"Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study","volume":"44","author":"Trottier","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jsbmb.2026.107059_bib17","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/ecco-jcc\/jjae096","article-title":"Inflammatory bowel disease associated with primary sclerosing cholangitis is associated with an altered gut microbiome and bile acid profile","volume":"18","author":"Leibovitzh","year":"2024","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.jsbmb.2026.107059_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000452","article-title":"Unique bile acid profiles in the bile ducts of patients with primary sclerosing cholangitis","volume":"8","author":"Kayashima","year":"2024","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jsbmb.2026.107059_bib19","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1096\/fasebj.8.15.8001744","article-title":"Bile acid synthesis from cholesterol: regulatory and auxiliary pathways","volume":"8","author":"Javitt","year":"1994","journal-title":"FASEB J."},{"key":"10.1016\/j.jsbmb.2026.107059_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jsbmb.2026.107059_bib21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.4254\/wjh.v8.i22.924","article-title":"Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications","volume":"8","author":"Nemes","year":"2016","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-3-031-43883-7_18","article-title":"Oxy- and Phytosterols as Biomarkers: Current Status and Future Perspectives","volume":"1440","author":"Olkkonen","year":"2024","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106621","article-title":"Unique sterol metabolite shifts in inflammatory bowel disease and primary sclerosing cholangitis","volume":"245","author":"Matysik","year":"2025","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib24","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1126\/science.290.5497.1771","article-title":"Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters","volume":"290","author":"Berge","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2026.107059_bib25","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1055\/a-2060-0935","article-title":"Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) \u2013 Februar 2023 \u2013 AWMF-Registriernummer: 021-009","volume":"61","author":"Kucharzik","year":"2023","journal-title":"Z. Gastroenterol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2019.03.009","article-title":"The isoflavones genistein and daidzein increase hepatic concentration of thyroid hormones and affect cholesterol metabolism in middle-aged male rats","volume":"190","author":"Sosic-Jurjevic","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22157898","article-title":"Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury","volume":"22","author":"Christidis","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2026.107059_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045181","article-title":"IP-10 can be measured in dried plasma spots in patients with chronic hepatitis C infection","volume":"7","author":"Ruhwald","year":"2012","journal-title":"PLoS. One"},{"key":"10.1016\/j.jsbmb.2026.107059_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.14348\/molcells.2017.0051","article-title":"IP-10 Expression in Patients with Chronic HBV Infection and Its Ability to Predict the Decrease in HBsAg Levels after Treatment with Entecavir","volume":"40","author":"Zhao","year":"2017","journal-title":"Mol. Cells"},{"key":"10.1016\/j.jsbmb.2026.107059_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.23631","article-title":"Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression","volume":"52","author":"Sinakos","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jsbmb.2026.107059_bib31","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jsbmb.2026.107059_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2172671","article-title":"Bile acids as modulators of gut microbiota composition and function","volume":"15","author":"Larabi","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jsbmb.2026.107059_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12263-010-0182-x","article-title":"Phytosterols and phytosterolemia: gene-diet interactions","volume":"6","author":"Izar","year":"2011","journal-title":"Genes. Nutr."},{"key":"10.1016\/j.jsbmb.2026.107059_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ejlt.201800054","article-title":"Relationship Between Dietary Sterols and Gut Microbiota: A Review","volume":"120","author":"Cuevas-Tena","year":"2018","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib35","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0140-6736(25)02582-6","article-title":"Primary sclerosing cholangitis","volume":"407","author":"von Seth","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2026.107059_bib36","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s12072-013-9445-0","article-title":"CXC chemokine IP-10: a key actor in liver disease?","volume":"7","author":"Chen","year":"2013","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jsbmb.2026.107059_bib37","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","article-title":"CXCR3 in T cell function","volume":"317","author":"Groom","year":"2011","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.jsbmb.2026.107059_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.crbiot.2023.100130","article-title":"Importance of IP-10 as a biomarker of host immune response: Critical perspective as a target for biosensing","volume":"5","author":"Madhurantakam","year":"2023","journal-title":"Curr. Res. Biotech."},{"key":"10.1016\/j.jsbmb.2026.107059_bib39","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.jhep.2014.12.034","article-title":"Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity","volume":"62","author":"Mueller","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","article-title":"Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders","volume":"35","author":"Lazaridis","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jsbmb.2026.107059_bib41","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.gastha.2023.09.013","article-title":"Farnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases","volume":"3","author":"Almeqdadi","year":"2024","journal-title":"Gastro Hep Adv."},{"key":"10.1016\/j.jsbmb.2026.107059_bib42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/gastroent16030030","article-title":"Ileal Bile Acid Transporter Inhibitors for Adult Patients with Autoimmune Cholestatic Liver Diseases: A Systematic Review and Meta-Analysis","volume":"16","author":"Silveira","year":"2025","journal-title":"Gastroenterol. Insights"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076026001251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076026001251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:58:01Z","timestamp":1783407481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076026001251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S0960076026001251"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.107059","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-gamma-inducible protein-10 is associated to increased primary bile acids and fibrosis in primary sclerosing cholangitis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.107059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107059"}}